semaglutide injection sites weight loss NYC Wegovy & Ozempic Weight Loss

Diabetologia (2019) 62(7):115466

It is associated with a 35% to 40% increased risk of BC recurrence and mortality, particularly among patients with estrogen receptor-positive tumors

The FDA has long harbored safety concerns when drugs are compounded in bulk, particularly when they are distributed via mail or through doctors offices, where they might sit on a shelf for long periods

A January 2026 BMJ meta-analysis of 9,341 adults across 37 studies found that once patients stop GLP-1 medications, blood pressure, glucose, and lipid markers are all projected to return to pre-treatment baseline within about 1.4 to 1.5 years.[1] This data raises an important question

doi: 10.1136/ard.52.7.494